| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUROL.2011.666 |
| P8608 | Fatcat ID | release_wsisabk46vaqbm5roldgetwx5y |
| P932 | PMC publication ID | 4004919 |
| P698 | PubMed publication ID | 22332189 |
| P5875 | ResearchGate publication ID | 221830396 |
| P50 | author | William J. Jagust | Q56863004 |
| P2093 | author name string | Elizabeth C Mormino | |
| Cindee M Madison | |||
| Audrey Perrotin | |||
| Amynta O Hayenga | |||
| P2860 | cites work | Neuropathological stageing of Alzheimer-related changes | Q27860862 |
| Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B | Q29012704 | ||
| Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade | Q29614407 | ||
| Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain | Q29614725 | ||
| An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest | Q29615076 | ||
| Neural correlates of self-reflection | Q30706239 | ||
| Comparative evaluation of MR-based partial-volume correction schemes for PET. | Q33885188 | ||
| Are memory complaints predictive for dementia? A review of clinical and population-based studies | Q34103134 | ||
| Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints | Q36351419 | ||
| Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI | Q36368924 | ||
| Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints | Q36661066 | ||
| Distribution volume ratios without blood sampling from graphical analysis of PET data | Q36817029 | ||
| Frequent amyloid deposition without significant cognitive impairment among the elderly | Q37085957 | ||
| Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects | Q37181281 | ||
| The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease | Q37218286 | ||
| Memory complaints are related to Alzheimer disease pathology in older persons | Q37339710 | ||
| Outcome over seven years of healthy adults with and without subjective cognitive impairment | Q37414902 | ||
| Metacognitive evaluation, self-relevance, and the right prefrontal cortex | Q38421529 | ||
| Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease. | Q40336916 | ||
| Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. | Q40382649 | ||
| Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. | Q40415499 | ||
| Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease. | Q40466314 | ||
| Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele. | Q41678436 | ||
| Relationship between atrophy and beta-amyloid deposition in Alzheimer disease | Q43107490 | ||
| Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents | Q44474556 | ||
| Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease | Q45039020 | ||
| Depression, APOE genotype and subjective memory impairment: a cross-sectional study in an African-Caribbean population | Q46704745 | ||
| Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease | Q46956885 | ||
| Imaging beta-amyloid burden in aging and dementia. | Q48168226 | ||
| Characterising error-awareness of attentional lapses and inhibitory control failures in patients with traumatic brain injury | Q48313229 | ||
| Volume loss of the medial temporal lobe structures in subjective memory impairment | Q48328719 | ||
| (11)C-PIB PET in subjective cognitive impairment. | Q48402915 | ||
| Subjective cognitive failures and hippocampal volume in elderly with white matter lesions. | Q48891510 | ||
| Memory complaints in a community sample aged 60-64 years: associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matter hyperintensities. | Q49027631 | ||
| Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. | Q51059680 | ||
| Subjective memory complaints, education, and risk of Alzheimer's disease. | Q51905326 | ||
| Cognitive components of deficit awareness in Alzheimer's disease. | Q51954141 | ||
| Neuroimaging correlates of subjective memory deficits in a community population. | Q51958544 | ||
| Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study. | Q52010872 | ||
| Memory complaints in older adults. Fact or fiction? | Q52102006 | ||
| Volume reduction of the entorhinal cortex in subjective memory impairment. | Q53273914 | ||
| Neuropathology of Alzheimer's disease. | Q53377175 | ||
| Mild cognitive impairment | Q57306293 | ||
| [11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease | Q60451990 | ||
| P433 | issue | 2 | |
| P921 | main subject | positron emission tomography | Q208376 |
| Pittsburgh compound B | Q4047010 | ||
| P304 | page(s) | 223-229 | |
| P577 | publication date | 2012-02-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals | |
| P478 | volume | 69 |
| Q37695206 | A 'Disease Severity Index' to identify individuals with Subjective Memory Decline who will progress to mild cognitive impairment or dementia. |
| Q37590389 | A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease |
| Q60946462 | A Homeostatic Model of Subjective Cognitive Decline |
| Q47644078 | A Link between Subjective Perceptions of Memory and Physical Function: Implications for Subjective Cognitive Decline. |
| Q35833282 | A Mutual Self- and Informant-Report of Cognitive Complaint Correlates with Neuropathological Outcomes in Mild Cognitive Impairment |
| Q35049917 | A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease |
| Q36090120 | APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons. |
| Q45305518 | Adherence to Mediterranean diet and subjective cognitive function in men. |
| Q37435036 | Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study |
| Q37278362 | Altered Brain Connectivity in Early Postmenopausal Women with Subjective Cognitive Impairment |
| Q47127718 | Amyloid Positivity Using [18F]Flutemetamol-PET and Cognitive Deficits in Nondemented Community-Dwelling Older Adults |
| Q33754010 | Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia |
| Q37254106 | Amyloid deposition and cognition in older adults: the effects of premorbid intellect |
| Q38250091 | Amyloid imaging in Alzheimer's disease: a literature review. |
| Q37184248 | Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. |
| Q36361729 | Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot Study |
| Q61809047 | Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project |
| Q100439585 | An approach to classifying subjective cognitive decline in community-dwelling elders |
| Q36137528 | Ascertaining Subjective Cognitive Decline: A Comparison of Approaches and Evidence for Using an Age-Anchored Reference Group |
| Q50533465 | Association between subjective memory assessment and associative memory performance: Role of ad risk factors. |
| Q38416584 | Biochemical and neuroimaging studies in subjective cognitive decline: progress and perspectives. |
| Q92875715 | Biomarker-Based Signature of Alzheimer's Disease in Pre-MCI Individuals |
| Q48467159 | Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment. |
| Q48918777 | Changes in cognitive function and brain glucose metabolism in elderly women with subjective memory impairment: a 24-month prospective pilot study. |
| Q92413002 | Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET |
| Q53396885 | Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia. |
| Q47658138 | Cognitive Complaints in Memory Clinic Patients and in Depressive Patients: An Interpretative Phenomenological Analysis |
| Q37252248 | Cognitive aging in persons with minimal amyloid-β and white matter hyperintensities |
| Q48137093 | Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia |
| Q40457852 | Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects. |
| Q91735272 | Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time |
| Q36569761 | Development of a subjective cognitive decline questionnaire using item response theory: a pilot study |
| Q48058922 | Differences in quantitative methods for measuring subjective cognitive decline - results from a prospective memory clinic study |
| Q39199825 | Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? |
| Q35911118 | Establishing Clinical Relevance in Preclinical Alzheimer's Disease |
| Q47574138 | Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging |
| Q57473764 | Frequency and Correlates of Subjective Cognitive Impairment in HIV Disease |
| Q91302033 | Functional cognitive disorders: a systematic review |
| Q55238739 | Gender Differences in Elderly With Subjective Cognitive Decline. |
| Q33770441 | Gene-environment interactions: lifetime cognitive activity, APOE genotype, and β-amyloid burden |
| Q50706730 | Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline. |
| Q38851607 | Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden |
| Q36262285 | Hypertensive Disorders of Pregnancy Appear Not to Be Associated with Alzheimer's Disease Later in Life |
| Q57294832 | Impact of a Multidomain Intensive Lifestyle Intervention on Complaints About Memory, Problem-Solving, and Decision-Making Abilities: The Action for Health in Diabetes Randomized Controlled Clinical Trial |
| Q35041971 | Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders |
| Q90374528 | Interventions for subjective cognitive decline: systematic review and meta-analysis |
| Q35836847 | Let Food Be Thy Medicine: Diet, Nutrition, and Biomarkers' Risk of Alzheimer's Disease |
| Q93336290 | Long-term intake of vegetables and fruits and subjective cognitive function in US men |
| Q33726122 | Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample |
| Q36327068 | Memory complaints and risk of cognitive impairment after nearly 2 decades among older women |
| Q50445931 | Memory self-awareness in the preclinical and prodromal stages of Alzheimer's disease. |
| Q50657044 | Mindfulness Training for Older Adults with Subjective Cognitive Decline: Results from a Pilot Randomized Controlled Trial. |
| Q37694011 | Multimodal MRI-based Imputation of the Aβ+ in Early Mild Cognitive Impairment |
| Q49669992 | Network Disruption in the Preclinical Stages of Alzheimer's Disease: From Subjective Cognitive Decline to Mild Cognitive Impairment. |
| Q99607643 | Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease |
| Q33605578 | Neuroprotective pathways: lifestyle activity, brain pathology, and cognition in cognitively normal older adults |
| Q38749068 | Non-Pharmacologic Interventions for Older Adults with Subjective Cognitive Decline: Systematic Review, Meta-Analysis, and Preliminary Recommendations |
| Q58560363 | Online study partner-reported cognitive decline in the Brain Health Registry |
| Q90148782 | Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort |
| Q45305522 | Physical activity across adulthood and subjective cognitive function in older men. |
| Q30774130 | Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials |
| Q38847227 | Prevalence and predictors of subjective memory complaints in adult male carriers of the FMR1 premutation |
| Q37689697 | Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review |
| Q48114819 | Prospective memory and subjective memory decline: A neuropsychological indicator of memory difficulties in community-dwelling older people |
| Q37544208 | Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imaging. |
| Q102144055 | Quantitative informant- and self-reports of subjective cognitive decline predict amyloid beta PET outcomes in cognitively unimpaired individuals independently of age and APOE ε4 |
| Q57800439 | Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease |
| Q37616818 | Regional Cerebral Blood Flow in [123]I-IMP Single-photon Emission Computed Tomography and the Wechsler Memory Scale-revised in Nondemented Elderly Subjects with Subjective Cognitive Impairment |
| Q38248954 | Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis |
| Q35611460 | Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease |
| Q31155701 | Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project |
| Q92825260 | Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain |
| Q35940991 | Subjective Cognitive Complaints, Personality and Brain Amyloid-beta in Cognitively Normal Older Adults |
| Q92584159 | Subjective Cognitive Decline and Alzheimer's Disease Spectrum Disorder |
| Q38592141 | Subjective Cognitive Decline from a Phenomenological Perspective: A Review of the Qualitative Literature |
| Q36197614 | Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies |
| Q58798017 | Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results |
| Q40335688 | Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden |
| Q50615863 | Subjective Memory Impairment and Gait Variability in Cognitively Healthy Individuals: Results from a Cross-Sectional Pilot Study. |
| Q38252671 | Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer's disease |
| Q36322792 | Subjective cognitive complaints and amyloid burden in cognitively normal older individuals |
| Q35850701 | Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly |
| Q34621679 | Subjective cognitive concerns, episodic memory, and the APOE ε4 allele |
| Q46683905 | Subjective cognitive decline and β-amyloid burden predict cognitive change in healthy elderly |
| Q47105654 | Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease? |
| Q30421568 | Subjective cognitive decline: self and informant comparisons |
| Q35545514 | Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD. |
| Q45891167 | Subjective memory complaints, depressive symptoms and cognition in patients attending a memory outpatient clinic |
| Q60707995 | Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD) |
| Q100750321 | Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort |
| Q50577957 | Subtle visuomotor difficulties in preclinical Alzheimer's disease. |
| Q37724226 | Synapse stability in the precuneus early in the progression of Alzheimer's disease |
| Q38668225 | Temporal Order of Alzheimer's Disease-Related Cognitive Marker Changes in BLSA and WRAP Longitudinal Studies |
| Q40194249 | The Association of Perceived Memory Loss with Osteoarthritis and Related Joint Pain in a Large Appalachian Population |
| Q27022753 | The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review |
| Q50533660 | The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline. |
| Q34849048 | The evolution of preclinical Alzheimer's disease: implications for prevention trials |
| Q37715654 | The influence of demographic factors on subjective cognitive concerns and beta-amyloid |
| Q36979972 | The neuropsychology of normal aging and preclinical Alzheimer's disease |
| Q47721943 | The psychological impact of disclosing amyloid status to Japanese elderly: a preliminary study on asymptomatic patients with subjective cognitive decline |
| Q103826128 | U.S. state correlations between oral health metrics and Alzheimer's disease mortality, prevalence and subjective cognitive decline prevalence |
| Q64069093 | Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints |
| Q36573616 | Vulnerable neural systems and the borderland of brain aging and neurodegeneration |
| Q92318432 | Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study |
Search more.